Team Publications

2024

  • Bhatt NS, Meyer CL, Mau LW, Auletta JJ, Baker KS, Broglie L, Carpenter PA, Choi SW, Dandoy CE, Devine S, Phelan R Return to school practices after hematopoietic cell transplantation: a survey of transplant centers in the United States. Bone Marrow Transplant 2024 Feb 20
  • Hill JA, Martens MJ, Young JH, Bhavsar K, Kou J, Chen M, Lee LW, Baluch A, Dhodapkar MV, Nakamura R, Peyton K, Howard DS, Ibrahim U, Shahid Z, Armistead P, Westervelt P, McCarty J, McGuirk J, Hamadani M, DeWolf S, Hosszu K, Sharon E, Spahn A, Toor AA, Waldvogel S, Greenberger LM, Auletta JJ, Horowitz MM, Riches ML, Perales MA SARS-CoV-2 vaccination in the first year after hematopoietic cell transplant or chimeric antigen receptor T cell therapy: A prospective, multicenter, observational study (BMT CTN 2101). medRxiv 2024 Jan 25
  • Kim YY, Gryder BE, Sinniah R, Peach ML, Shern JF, Abdelmaksoud A, Pomella S, Woldemichael GM, Stanton BZ, Milewski D, Barchi JJ Jr, Schneekloth JS Jr, Chari R, Kowalczyk JT, Shenoy SR, Evans JR, Song YK, Wang C, Wen X, Chou HC, Gangalapudi V, Esposito D, Jones J, Procter L, O'Neill M, Jenkins LM, Tarasova NI, Wei JS, McMahon JB, O'Keefe BR, Hawley RG, Khan J KDM3B inhibitors disrupt the oncogenic activity of PAX3-FOXO1 in fusion-positive rhabdomyosarcoma. Nat Commun 2024 Feb 24 15 1703

2023

  • Abdelghani E, Schieffer KM, Cottrell CE, Audino A, Zajo K, Shah N CHEK2 Alterations in Pediatric Malignancy: A Single-Institution Experience. Cancers (Basel) 2023 Mar 8 15
  • Abdelghani E, Waller AP, Wolfgang KJ, Stanek JR, Parikh SV, Rovin BH, Smoyer WE, Kerlin BA, the PNRC Investigators,, the NEPTUNE Investigators Exploring the Role of Antithrombin in Nephrotic Syndrome-Associated Hypercoagulopathy: A Multi-Cohort Study and Meta-Analysis. Clin J Am Soc Nephrol 2023 Feb 1 18 234-244
  • Auletta JJ MD, Kou J MS, Chen M MS, Bolon YT PhD, Broglie L MD, MS, Bupp C MPH, Christianson D BA, Cusatis RN PhD, Devine SM MD, Eapen M MBBS, MS, Flynn KE PhD, Hamadani M MD, Hengen M MBA, Lee SJ MD, MPH, Moskop A MD, MS, Page KM MD, Pasquini MC MD, MS, Perez WS MPH, Phelan R MD, MPH, Riches ML MD, MS, Rizzo JD MD, MS, Saber W MD, MS, Spellman SR MBS, Stefanski HE MD, PhD, Steinert P PhD, MBA, Tuschl E DNP, Yusuf R MBBS, PhD, Zhang MJ PhD, Shaw BE MD, PhD Real-world data showing trends and outcomes by race and ethnicity in allogeneic hematopoietic cell transplantation: a report from the Center for International Blood and Marrow Transplant Research. Transplant Cell Ther 2023 Mar 14
  • Auletta JJ On a collision course: SARS-CoV-2 variants and CAR T cells. Blood Adv 2023 Jun 13 7 2643-2644
  • Auletta JJ, Holter-Chakrabarty J, Jain T, Miller B, Ward E, Khera N, Gomez-Arteaga A, Hall A, Nemecek E, Robb D, Yusuf RA, Davies SM, ACCESS Workshop Team Members Proceedings of the 2023 Second Annual ASTCT-NMDP ACCESS Initiative Workshop. Transplant Cell Ther 2023 Oct 5
  • Auletta JJ, Khera N, DeMartino P, Kelkar AH, Yusuf RA, Davies SM, Knutson J, Beaver E, Maloney A, Majhail NS Assessing Medicaid coverage for hematopoietic cell transplantation and chimeric antigen receptor T-cell therapy: A project from the ASTCT-NMDP ACCESS Initiative. Transplant Cell Ther 2023 Aug 12
  • Bajaj N, Phelan J, McConnell EE, Reed SM A narrative medicine intervention in pediatric residents led to sustained improvements in resident well-being. Ann Med 2023 Dec 55 849-859
  • Bala N, Stanek J, Rodriguez V, Villella A Prevalence and Risk Factors for Pulmonary Embolism in Pediatric Sickle Cell Disease: A National Administrative Database Study. Pediatr Hematol Oncol 2023 Jan 16 1-13
  • Beall M, Deep K, Tram NK, Nabavinia M, Janse SA, Chou TH, Hardisky D, Bobbey AJ, Kerlin BA, Audino AN, Stacy MR Prognostic Value of Fluorine-18-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Imaging for Predicting Venous Thromboembolism in Children With Lymphoma. Circ Cardiovasc Imaging 2023 Apr 16 e014992
  • Bhattacharyya S, Oblinger JL, Beauchamp RL, Yin Z, Erdin S, Koundinya P, Ware AD, Ferrer M, Jordan JT, Plotkin SR, Xu L, Chang LS, Ramesh V Proteasomal pathway inhibition as a potential therapy for NF2-associated meningioma and schwannoma. Neuro Oncol 2023 Feb 20
  • Bjorklund KA, Alexander J, Tulchin-Francis K, Yanes NS, Singh S, Valerio I, Klingele K, Scharschmidt T Targeted Muscle Reinnervation for Limb Amputation to Avoid Neuroma and Phantom Limb Pain in Patients Treated at a Pediatric Hospital. Plast Reconstr Surg Glob Open 2023 Apr 11 e4944
  • Bowman S, Stanek J, Bajwa R, Polishchuk V, Abu-Arja R, Rangarajan HG CD34 Stem Cell Boost in Pediatric Allogeneic Stem Cell Transplant Recipients: A Case Series and Review of Literature. Clin Hematol Int 2023 Apr 7
  • Chory EJ, Wang M, Ceribelli M, Michalowska AM, Golas S, Beck E, Klumpp-Thomas C, Chen L, McKnight C, Itkin Z, Wilson KM, Holland D, Divakaran S, Bradner J, Khan J, Gryder BE, Thomas CJ, Stanton BZ High-throughput Approaches to Uncover Synergistic Drug Combinations in Leukemia. SLAS Discov 2023 Apr 28
  • Cripe TP Cancer gene therapy bears fruit. Mol Ther 2023 Jan 11
  • Desai AV, Elmuti L, Cahaney C, De Guzman RM, Streby KA, Cohn SL Multimodality treatment for recurrent neuroblastoma in the central nervous system. Pediatr Blood Cancer 2023 Jan 31 e30227
  • Devine SM, Bo-Subait S, Kuxhausen M, Spellman SR, Bupp C, Ahn KW, Stefanski HE, Auletta JJ, Logan BR, Shaw BE Clinical Impact of Cryopreservation of Allogeneic Hematopoietic Cell Grafts During the Onset of the COVID-19 Pandemic. Blood Adv 2023 Apr 10
  • Dillon LW, Gui G, Page KM, Ravindra N, Wong ZC, Andrew G, Mukherjee D, Zeger SL, El Chaer F, Spellman S, Howard A, Chen K, Auletta J, Devine SM, Jimenez Jimenez AM, De Lima MJG, Litzow MR, Kebriaei P, Saber W, Weisdorf DJ, Hourigan CS DNA Sequencing to Detect Residual Disease in Adults With Acute Myeloid Leukemia Prior to Hematopoietic Cell Transplant. JAMA 2023 Mar 7 329 745-755
  • Esteghamat NS, Brunson A, Rosenberg AS, Schonfeld SJ, Valcarcel B, Abrahão R, Cooley JJP, Meyer CL, Auletta JJ, Morton LM, Muffly L, Wun T, Keegan THM Utilization of Autologous Hematopoietic Cell Transplantation Over Time in Multiple Myeloma: A Population-Based Study. Clin Lymphoma Myeloma Leuk 2023 Dec 20
  • Gui G, Dillon LW, Ravindra N, Hegde PS, Andrew G, Mukherjee D, Wong Z, Auletta J, Chaer FE, Chen E, Chen YB, Corner A, Devine SM, Iyer S, Jimenez Jimenez AM, De Lima MJG, Litzow MR, Kebriaei P, Spellman SR, Zeger SL, Page KM, Hourigan CS Measurable Residual IDH1 before Allogeneic Transplant for Acute Myeloid Leukemia. medRxiv 2023 Aug 1
  • Hill JA, Martens MJ, Young JH, Bhavsar K, Kou J, Chen M, Lee LW, Baluch A, Dhodapkar MV, Nakamura R, Peyton K, Shahid Z, Armistead P, Westervelt P, McCarty J, McGuirk J, Hamadani M, DeWolf S, Hosszu K, Sharon E, Spahn A, Toor AA, Waldvogel S, Greenberger LM, Auletta JJ, Horowitz MM, Riches ML, Perales MA SARS-CoV-2 vaccination in the first year after allogeneic hematopoietic cell transplant: a prospective, multicentre, observational study. EClinicalMedicine 2023 May 59 101983
  • Kent MR, Calderon D, Silvius KM, Kucinski JP, LaVigne CA, Cannon MV, Kendall GC Zebrafish her3 knockout impacts developmental and cancer-related gene signatures. Dev Biol 2023 Jan 23 496 1-14
  • Khawaja F, Papanicolaou G, Dadwal S, Pergam SA, Wingard JR, Boghdadly ZE, Abidi MZ, Waghmare A, Shahid Z, Michaels L, Hill JA, Kamboj M, Boeckh M, Auletta JJ, Chemaly RF Frequently Asked Questions on Coronavirus Disease 2019 Vaccination for Hematopoietic Cell Transplantation and Chimeric Antigen Receptor T-Cell Recipients From the American Society for Transplantation and Cellular Therapy and the American Society of Hematology. Transplant Cell Ther 2023 Jan 29 10-18
  • Knight TE, Ahn KW, Hebert KM, Atshan R, Wall DA, Chiengthong K, Lund TC, Prestidge T, Rangarajan HG, Dvorak CC, Auletta JJ, Kent M, Hashem H, Talano JA, Rotz SJ, Fraint E, Myers KC, Leung W, Sharma A, Bhatt NS, Driscoll TA, Yu LC, Schultz KR, Qayed M, Broglie L, Eapen M, Yanik GA No impact of CD34(+) cell dose on outcome among children undergoing autologous hematopoietic stem cell transplant for high-risk neuroblastoma. Bone Marrow Transplant 2023 Sep 4
  • Knight TE, Ahn KW, Hebert KM, Atshan R, Wall DA, Chiengthong K, Rotz SJ, Fraint E, Rangarajan HG, Auletta JJ, Sharma A, Kitko CL, Hashem H, Williams KM, Wirk B, Dvorak CC, Myers KC, Pulsipher MA, Warwick AB, Lalefar NR, Schultz KR, Qayed M, Broglie L, Eapen M, Yanik GA Effect of Autograft CD34(+) Dose on Outcome in Pediatric Patients Undergoing Autologous Hematopoietic Stem Cell Transplant for Central Nervous System Tumors. Transplant Cell Ther 2023 Mar 27
  • Kumar R, Bakeer N, Dawson J, Al-Mughairy A, Stanek J, Dunn A, Male C, Chan A, Williams S Impact of SERPINC1 mutation on thrombotic phenotype in children with congenital antithrombin deficiency-first analysis of the International Society on Thrombosis and Haemostasis pediatric antithrombin deficiency database and biorepository. J Thromb Haemost 2023 Feb 9
  • Lévy R, Gothe F, Momenilandi M, Magg T, Materna M, Peters P, Raedler J, Philippot Q, Rack-Hoch AL, Langlais D, Bourgey M, Lanz AL, Ogishi M, Rosain J, Martin E, Latour S, Vladikine N, Distefano M, Khan T, Rapaport F, Schulz MS, Holzer U, Fasth A, Sogkas G, Speckmann C, Troilo A, Bigley V, Roppelt A, Dinur-Schejter Y, Toker O, Bronken Martinsen KH, Sherkat R, Somekh I, Somech R, Shouval DS, Kühl JS, Ip W, McDermott EM, Cliffe L, Ozen A, Baris S, Rangarajan HG, Jouanguy E, Puel A, Bustamante J, Alyanakian MA, Fusaro M, Wang Y, Kong XF, Cobat A, Boutboul D, Castelle M, Aguilar C, Hermine O, Cheminant M, Suarez F, Yildiran A, Bousfiha A, Al-Mousa H, Alsohime F, Cagdas D, Abraham RS, Knutsen AP, Fevang B, Bhattad S, Kiykim A, Erman B, Arikoglu T, Unal E, Kumar A, Geier CB, Baumann U, Neven B, CARMIL2 Consortium, Rohlfs M, Walz C, Abel L, Malissen B, Marr N, Klein C, Casanova JL, Hauck F, Béziat V Human CARMIL2 deficiency underlies a broader immunological and clinical phenotype than CD28 deficiency. J Exp Med 2023 Feb 6 220
  • Mahlangu J, Kaczmarek R, von Drygalski A, Shapiro S, Chou SC, Ozelo MC, Kenet G, Peyvandi F, Wang M, Madan B, Key NS, Laffan M, Dunn AL, Mason J, Quon DV, Symington E, Leavitt AD, Oldenburg J, Chambost H, Reding MT, Jayaram K, Yu H, Mahajan R, Chavele KM, Reddy DB, Henshaw J, Robinson TM, Wong WY, Pipe SW, GENEr8-1 Trial Group Two-Year Outcomes of Valoctocogene Roxaparvovec Therapy for Hemophilia A. N Engl J Med 2023 Feb 23 388 694-705
  • Marinoff AE, Spurr LF, Fong C, Li YY, Forrest SJ, Ward A, Doan D, Corson L, Mauguen A, Pinto N, Maese L, Colace S, Macy ME, Kim A, Sabnis AJ, Applebaum MA, Laetsch TW, Glade-Bender J, Weiser DA, Anderson M, Crompton BD, Meyers P, Zehir A, MacConaill L, Lindeman N, Nowak JA, Ladanyi M, Church AJ, Cherniack AD, Shukla N, Janeway KA Clinical Targeted Next-Generation Panel Sequencing Reveals MYC Amplification Is a Poor Prognostic Factor in Osteosarcoma. JCO Precis Oncol 2023 Mar 7 e2200334
  • Masih KE, Gardner RA, Chou HC, Abdelmaksoud A, Song YK, Mariani L, Gangalapudi V, Gryder BE, Wilson AL, Adebola SO, Stanton BZ, Wang C, Milewski D, Kim YY, Tian M, Cheuk AT, Wen X, Zhang Y, Altan-Bonnet G, Kelly MC, Wei JS, Bulyk ML, Jensen MC, Orentas RJ, Khan J A stem cell epigenome is associated with primary nonresponse to CD19 CAR T-cells in pediatric acute lymphoblastic leukemia. Blood Adv 2023 Jan 6
  • Mehyar LS, Hartog L, Kahwash SB, Abu-Arja R, Ranalli M, Rangarajan HG Long term survivor of MOZ-p300 therapy-related acute myeloid leukemia after matched unrelated donor bone marrow transplantation. Leuk Lymphoma 2023 Apr 20 1-4
  • Mehyar LS, Hartog L, Kahwash SB, Abu-Arja R, Ranalli M, Rangarajan HG Long term survivor of MOZ-p300 therapy-related acute myeloid leukemia after matched unrelated donor bone marrow transplantation. Leuk Lymphoma 2023 Apr 20 1-4
  • Miller A, Davies J, Young K, Eckman E, Lo MY, Erskine H, Knutson L, Ondricek S, Margolis JM, Auletta JJ, Miller JP, Stefanski HE, Devine S, Pham HP The effect of increased collect pump rate on collection efficiency in hematopoietic progenitor cell collection by apheresis in allogeneic adult donors-A single center analysis. Transfusion 2023 Sep 5
  • Munro MG, Mast AE, Powers JM, Kouides PA, O'Brien SH, Richards T, Lavin M, Levy BS The relationship between heavy menstrual bleeding, iron deficiency, and iron deficiency anemia. Am J Obstet Gynecol 2023 Jan 24
  • Ngwube A, Rangarajan H, Shah N Role of abatacept in the prevention of graft-versus-host disease: current perspectives. Ther Adv Hematol 2023 14 20406207231152644
  • O'Brien S Acquiring a new diagnostic approach for aVWS. Blood 2023 Jan 5 141 7-9
  • Oluwakorede O, Joan R, Dunn AL, Gleason Courtney N Mild Hemophilia In A Competitive High School Soccer Player: A Case Report. J Athl Train 2023 Mar 14
  • Parthasarathy J, Jonard B, Rees M, Selvaraj B, Scharschmidt T Virtual surgical planning and 3D printing in pediatric musculoskeletal oncological resections: a proof-of-concept description. Int J Comput Assist Radiol Surg 2023 Jan 18 95-104
  • Paul R, Niedner M, Riggs R, Richardson T, DeSouza HG, Auletta JJ, Balamuth F, Campbell D, Depinet H, Hueschen L, Huskins WC, Kandil SB, Larsen G, Mack EH, Priebe GP, Rutman LE, Schafer M, Scott H, Silver P, Stalets EL, Wathen BA, Macias CG, Brilli RJ, IPSO COLLABORATIVE INVESTIGATORS Bundled Care to Reduce Sepsis Mortality: The Improving Pediatric Sepsis Outcomes (IPSO) Collaborative. Pediatrics 2023 Aug 1 152
  • Picca A, Sankar AD, Jacobson-Kelly AE, Rodriguez V Unprovoked Arterial Thrombosis: Clinical Presentation of Fibromuscular Dysplasia. Clin Pediatr (Phila) 2023 Apr 18 99228231169098
  • Picca A, Sankar AD, Jacobson-Kelly AE, Rodriguez V Unprovoked Arterial Thrombosis: Clinical Presentation of Fibromuscular Dysplasia. Clin Pediatr (Phila) 2023 Apr 18 99228231169098
  • Reed S, Mink R, Stanek J, Tyrrell L, Li ST Are Final Residency Milestones Correlated with Early Fellowship Performance in Pediatrics? Acad Med 2023 Mar 22
  • Reed S, Picca A, Lockwood L, Thoreson L, Burke AE, Mahan JD, Schumacher DJ, Gifford KA A Qualitative Analysis of Assessment and Evaluation Practices within the Individualized Curriculum. Acad Pediatr 2023 Apr 20
  • Rodriguez V, Stanek J, Cua CL, Sankar A, Giver J, Monda K, Canini J, Dunn AL, Kerlin BA A regional anticoagulation program improves safety and outcomes for both children and adults. J Thromb Thrombolysis 2023 Apr 24
  • Rodriguez V, Stanek J, Cua CL, Sankar A, Giver J, Monda K, Canini J, Dunn AL, Kerlin BA A regional anticoagulation program improves safety and outcomes for both children and adults. J Thromb Thrombolysis 2023 Apr 24
  • Setty BA, Gikandi A, DuBois SG Ewing Sarcoma Drug Therapy: Current Standard of Care and Emerging Agents. Paediatr Drugs 2023 Apr 4
  • Shackleford TJ, Hariharan S, Vaseva AV, Alagoa K, Espinoza M, Bid HK, Li F, Zhong H, Phelps DA, Roberts RD, Cam H, London CA, Guttridge DC, Chen Y, Rao M, Shiio Y, Houghton PJ Redundant Signaling as the Predominant mechanism for Resistance to Antibodies Targeting IGF-1R in Cells Derived from Childhood Sarcoma. Mol Cancer Ther 2023 Jan 24
  • Smith J, Jacobson-Kelly A, Donegan A, Boyle B, Maltz RM, Michel HK, Dotson JL Diagnosis and Treatment of Iron Deficiency and Anemia in Youth With Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr 2023 Mar 1 76 313-318
  • Sreenivas P, Wang L, Wang M, Challa A, Modi P, Hensch NR, Gryder B, Chou HC, Zhao XR, Sunkel B, Moreno-Campos R, Khan J, Stanton BZ, Ignatius MS A SNAI2/CTCF Interaction is Required for NOTCH1 Expression in Rhabdomyosarcoma. Mol Cell Biol 2023 Oct 26 1-19
  • Tallan A, Hoffman RA, Stanton BZ Functional Epigenomics: Pioneering Changes in Chromatin Structure. Biochemistry 2023 Feb 27
  • Tram NK, Chou TH, Janse SA, Bobbey AJ, Audino AN, Onofrey JA, Stacy MR Deep learning of image-derived measures of body composition in pediatric, adolescent, and young adult lymphoma: association with late treatment effects. Eur Radiol 2023 Mar 29
  • Tran DQ, Benson CC, Boice JA, Chitlur M, Dunn AL, Escobar MA, Gupta K, Johnsen JM, Jorgenson J, Martin SD, Martin S, Meeks SL, Narvaez AA Jr, Quon DV, Reding MT, Reiss UM, Savage B, Schafer K, Steiner B, Thornburg C, Volland LM, von Drygalski A Building the foundation for a community-generated national research blueprint for inherited bleeding disorders: research priorities to transform the care of people with hemophilia. Expert Rev Hematol 2023 Mar 16 19-37
  • Ustun C, Chen M, Kim S, Auletta JJ, Batista MV, Battiwalla M, Cerny J, Gowda L, Hill JA, Liu H, Munshi PN, Nathan S, Seftel MD, Wingard JR, Chemaly RF, Dandoy CE, Perales MA, Riches M, Papanicolaou GA Post-transplantation cyclophosphamide is associated with increased bacterial infections. Bone Marrow Transplant 2023 Oct 31
  • Valcarcel B, Schonfeld SJ, Meyer CL, Brunson A, Cooley JJP, Abrahão R, Wun T, Auletta JJ, Gadalla SM, Engels E, Albert PS, Spellman SR, Rizzo JD, Shaw BE, Muffly L, Keegan THM, Morton LM Comparison of vital status, cause of death, and follow-up after HCT in linked CIBMTR and California Cancer Registry data, 1991-2018. Transplant Cell Ther 2023 Nov 17
  • Waller J, Bican R, Collichio D, Frey C, Zerkle D, Duffey T, Stanek J, Reader B, Gonzales A, Auletta JJ Development of a Novel Massage Therapy Outcome Measure for Children and Young Adults Receiving Hematopoietic Cell Transplant. Int J Ther Massage Bodywork 2023 Sep 16 35-43
  • Wang M, Sreenivas P, Sunkel BD, Wang L, Ignatius M, Stanton BZ The 3D chromatin landscape of rhabdomyosarcoma. NAR Cancer 2023 Sep 5 zcad028
  • Watson S, LaVigne CA, Xu L, Surdez D, Cyrta J, Calderon D, Cannon MV, Kent MR, Silvius KM, Kucinski JP, Harrison EN, Murchison W, Rakheja D, Tirode F, Delattre O, Amatruda JF, Kendall GC VGLL2-NCOA2 leverages developmental programs for pediatric sarcomagenesis. Cell Rep 2023 Jan 18 42 112013
  • Yusuf RA, Preussler JM, Meyer CL, Schoeppner K, Sees Coles JA, Ruffin A, McCann M, Devine SM, Auletta JJ Reducing barriers of access and care related to hematopoietic cell transplantation and cellular therapy: The mission-driven role of the national marrow donor program. Best Pract Res Clin Haematol 2023 Jun 36 101480

Show More